Quantbot Technologies’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Quantbot Technologies’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-183,907	Closed	-$369K	–	2250
2022 Q2	$369K	Sell	183,907 -21,493	-10%	-$37.2K	0.03%	692
2022 Q1	$478K	Buy	+205,400	New	+$641K	0.04%	592
2016 Q1	–	Sell	-1,356	Closed	-$11K	–	1477
2015 Q4	$11K	Buy	1,356 +793	+141%	+$6.69K	﹤0.01%	973
2015 Q3	$4K	Sell	563 -5,000	-90%	-$79.6K	﹤0.01%	1124
2015 Q2	$98K	Buy	+5,563	New	+$71.5K	0.02%	648

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Quantbot Technologies's SRNE Position: Q3 2022 in Review

Quantbot Technologies sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 183,907 shares — an estimated $369K sold.

Quantbot Technologies first reported a position in SRNE in Q2 2015 and held it in 5 quarters. The position peaked at $478K in Q1 2022. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

Quantbot Technologies reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
Quantbot Technologies sold 183,907 Sorrento Therapeutics, Inc. shares in Q3 2022, an estimated $369K.
Quantbot Technologies first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 5 quarters.
Quantbot Technologies's Sorrento Therapeutics, Inc. position peaked at $478K in Q1 2022.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.